Dr. Rami Komrokji on the latest in MDS updates
Leah Sherwood
July 30, 2026
From EHA 2026, Dr. Komrokji shares the latest research in MDS, and his thoughts on what is next in the field.
2026 SOHO Brazil meeting attracts nearly 1,000 attendees
SOHO Insider Editors
July 30, 2026
Held annually in São Paulo, SOHO Brazil is part of the SOHO Ambassador Program, which supports regional meetings around the world to expand education in hematologic oncology.
Meet SOHO 2026 YIP recipient: Maria Felix Torres, MD
Leah Sherwood
July 30, 2026
During her residency in the United States, Dr. Torres became even more intrigued by the field. “I was able to see the impact of new therapies and how research is helping people have better access to treatment and better outcomes,” she said.
Drs. George Lenz and Loretta Nastoupil discuss phase 3 FRONTMIND study
Leah Sherwood
July 29, 2026
From EHA 2026, Dr. Loretta Nastoupil interviews Dr. Georg Lenz on the phase 3 FRONTMIND study, a randomised, double-blind, placebo-controlled study that evaluated tafasitamab plus lenalidomide and R-CHOP versus R-CHOP for first-line treatment of patients with high-risk diffuse large B-cell lymphoma.
What ASCO’s first ctDNA guideline means for lymphoma
Emily Hayes
July 28, 2026
ASCO’s first guideline on ctDNA testing in solid tumors and lymphoma was published by Christina Lockwood, PhD, head of the Genetics and Solid Tumors Laboratory at the University of Washington Medical Center, in the Journal of Clinical Oncology in June.
FDA accepts NDA for mezigdomide combo in relapsed or refractory myeloma
Leah Sherwood
July 27, 2026
The US Food and Drug Administration has accepted a new drug application for mezigdomide in combination with carfilzomib and dexamethasone (MeziKd) in patients with relapsed or refractory multiple myeloma.
Top Categories
POPULAR NEWS
SOHO Insider Podcast
SOHO Insider Print
Trending Now
Meetings
![Insider_YT_Feature_Pannunzio_CLFR2_400x400[15]](https://sohoinsider.com/wp-content/uploads/2026/06/Insider_YT_Feature_Pannunzio_CLFR2_400x40015.png)
Young Investigator Program
Ambassador Program
About Us/Editorial Board
SOHO Insider is the official media platform of the Society of Hematologic Oncology. The SOHO Insider Editorial Board is comprised of leading hematologists. Learn more about our editorial board and SOHO Insider platforms.
Join Us Today and Become a Part of the SOHO Community
- Instant connections to our SOHO Community of nearly 11,000 members
- Access to a comprehensive Resource Center that includes slides, publications, abstracts, videos & more
- Connection to our Ask-the-Expert forums and SOHO DocMatter Community for hematologic oncology discussions and education through our SOHO365 app
- Free online access to our official journal, Clinical Lymphoma Myeloma and Leukemia
- Free online and print subscription (US members) to our news publication, SOHO Insider
- Significant member-only discounts on meetings and events
- Early member-only registration and housing opportunities
- ... and much more!
SOHO Career Center
- Create a job seeker profile
- Perform intuitive searches for new jobs
- Auto-fill your resume through uploaded files
- Apply to new jobs through a streamlined workflow
- Receive email alerts when new relevant jobs are posted
To access the SOHO Career Center click the following link.
